Many players and research institutes operating in the gastric cancer diagnostics market are developing advanced products to expand their product portfolios and market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to gastric cancer diagnostic platforms are mentioned below:
Thus, such developments in AI-based gastric cancer diagnostics are likely to introduce new trends in the gastric cancer diagnostic procedure market during the forecast period.
Asia Pacific Gastric Cancer Diagnostic Procedure Market Overview
The Asia Pacific gastric cancer diagnostic procedure market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2022 and India is expected to exhibit substantial growth in the market during the forecast period. The gastric cancer diagnostic procedure market growth in these countries is attributed to the increasing incidence of gastric cancer, growing awareness of the disease and its diagnosis, rising geriatric population, and surging prevalence of H. pylori infection.
Asia Pacific Gastric Cancer Diagnostic Procedure Market Segmentation
The Asia Pacific gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.
Based on healthcare providers, the market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The hospitals segment held the largest gastric cancer diagnostic procedure market share in 2022.
Based on body fluid, the Asia Pacific gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest Asia Pacific gastric cancer diagnostic procedure market share in 2022.
Based on offering, the Asia Pacific gastric cancer diagnostic procedure market is segmented into instruments, reagents & consumables, and services. Reagents & consumables segment held largest Asia Pacific gastric cancer diagnostic procedure market share in 2022.
Based on Diagnostic procedure, the Asia Pacific gastric cancer diagnostic procedure market is categorized into endoscopic procedure, biopsy and tissue tests, lab test, in-vitro diagnostic tests, imaging test, molecular diagnostics, multiplexing molecular diagnostics, immunoassay, and others. The imaging segment held largest Asia Pacific gastric cancer diagnostic procedure market share in 2022.
Based on disease condition, the Asia Pacific gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger Asia Pacific gastric cancer diagnostic procedure market share in 2022.
The Asia Pacific gastric cancer diagnostic procedure market, by country, has been categorized into China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. China dominated the market in this region in 2022.
Atlas-Link Biotech Co Ltd; Bio-Rad Laboratories Inc; MiRXES Pte Ltd; Agilent Technologies Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; Vela Diagnostics Holding Pte Ltd; Myraid Genetics Inc. are the leading companies operating in the gastric cancer diagnostic procedure market in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 182.85 Million |
| Market Size by 2028 | US$ 349.33 Million |
| CAGR (2022 - 2028) | 11.4 % |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Healthcare Providers
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
The Asia Pacific Gastric Cancer Diagnostic Procedure Market is valued at US$ 182.85 Million in 2022, it is projected to reach US$ 349.33 Million by 2028.
As per our report Asia Pacific Gastric Cancer Diagnostic Procedure Market, the market size is valued at US$ 182.85 Million in 2022, projecting it to reach US$ 349.33 Million by 2028. This translates to a CAGR of approximately 11.4 % during the forecast period.
The Asia Pacific Gastric Cancer Diagnostic Procedure Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Gastric Cancer Diagnostic Procedure Market report:
The Asia Pacific Gastric Cancer Diagnostic Procedure Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Gastric Cancer Diagnostic Procedure Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Gastric Cancer Diagnostic Procedure Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Gastric Cancer Diagnostic Procedure Market
